Sichenzia Ross Ference represented BriaCell Therapeutics Corp. in the transaction. BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSXV: BCT) executed a public offering of 4,852,353 common units at...
Sichenzia Ross Ference represented BriaCell Therapeutics Corp. in the transaction. BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSXV: BCT) executed a public offering of 4,852,353 common units at...